1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cardiometabolic Drug News NOVEMBER 2014

Cardiometabolic Drug News NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Brief - FDA Advisory Committee Recommends Edoxaban Approval In NVAF
Industry Brief - Bayer Completes Acquisition Of Merck's Consumer Care Business; Collaboration Comes Into Effect
Industry Brief - BHV/Libbs Enter Licensing Deal For Remogliflozin
Industry Brief - Cardiorentis/Roche Enter Collaboration For Ularitide
Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance
Industry Brief - FDA Approves Once-Daily Xigduo XR For Adults With Type II Diabetes
Industry Brief - FDA Accepts NDA Filing For Empagliflozin/Metformin FDC
Industry Brief - Contrave Available In US Pharmacies
Industry Brief - FDA Approves Arbor's Sotylize
Industry Brief - The Medicines Company Sees US Angiomax Patent Victory
Industry Brief - Takeda Responds To Judgement In Actos Case
Industry Brief - Ranbaxy Gains US Fenofibrate Approval
Industry Brief - Cardio3 Receives Approval To Begin C-Cure Phase III HF Trial In Switzerland
Industry Brief - Amgen Files Alirocumab Lawsuit Against Sanofi/Regeneron
Industry Brief - Capricor To Acquire Natriuretic Peptide Patent Rights
Industry Brief - NeuroSearch Signs Agreement To Transfer Phase I-II Projects
Industry Brief - Novo Nordisk Invests In New Danish Laboratory Facility
Industry Brief - FDA Medicare Study Results For Pradaxa Revealed

Table Of Contents

Cardiometabolic Drug News NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.